Stocks
Corcept Therapeutics Incorporated (CORT) EBITDA margin US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 35.0% | 28.3% | 22.5% | 20.5% | 8.98% | -0.88% | ||
| Changes by years, y/y, % | -2pp | -7pp | -6pp | -2pp | -12pp | -24.6% | |||
Corcept Therapeutics Incorporated. EBITDA margin, %
Corcept Therapeutics Incorporated. EBITDA margin, changes, pp
Corcept Therapeutics Incorporated (CORT) EBITDA margin US GAAP (quarter values) |
||||||||
| FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | FY2026Q2 | LTM ? | |||
| EBITDA margin, % | ? | 16.5% | 7.57% | 5.14% | -26.8% | 18.3% | -0.88% | |
| Changes by years, y/y, % | -9pp | -18pp | -9pp | -29pp | +2pp | |||
| Changes by quarters, q/q, % | +14pp | -9pp | -2pp | -32pp | +45pp | |||
